Comparison of the Ca2+ movement by activation of α1-adrenoceptor subtypes in HEK-293 cells

Life Sciences

Volumn 61, Issue 21, 1997, Pages 2127-2136

  Tao, Liang ^b   Guan, Yong Yuan ^b   He, Hua ^b   Han, Chide ^a   Zhang, You Yi ^a   Sun, Jia Jun ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

1 adrenoceptor subtypes; Calcium entry; Calcium release; HEK 293 cells

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; CALCIUM CHANNEL; FURA 2; ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; CAFFEINE; CALCIUM; CYCLOPIAZONIC ACID; INDOLE DERIVATIVE; PHOSPHOLIPASE C; POTASSIUM; RYANODINE;

ARTICLE; CALCIUM ABSORPTION; CALCIUM TRANSPORT; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; RAT; ANIMAL; CATTLE; COMPARATIVE STUDY; GENETIC TRANSFECTION; HAMSTER; ION TRANSPORT; METABOLISM;

ANIMALS; CAFFEINE; CALCIUM; CATTLE; CELL LINE; CRICETINAE; EPINEPHRINE; HUMANS; INDOLES; ION TRANSPORT; PHOSPHOLIPASE C; POTASSIUM; RATS; RECEPTORS, ADRENERGIC, ALPHA-1; RYANODINE; TRANSFECTION;

EID: 0030609042     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00886-2     Document Type: Article

References (29)

1. K.P. MINNEMAN and T.A. ESBENSHADE, Ann.Rev.Pharmacol.Toxicol. 34 117-133 (1994).
2. M.C. MICHEL, B. KENNY and D.A. SCHWINN, Naunyn-Schmiedeberg's Arch.Pharmacol. 353 1-10 (1995).
3. J.P. HIEBLE, D.B. BYLUND, D.E. CLARKE, D.C. EIKENBURG, S.Z. LANGER, R.J. LEFKOWITZ, K.P. MINNEMAN and R.R. RUFFOLO, Pharmacol.Rev. 47 267-270 (1995).
4. C. HAN, P.W. ABEL and K.P. MINNEMAN, Nature(lond.) 392 333-335 (1987).
5. K.P. MINNEMAN, C. HAN and P.W. ABEL, Mol.Pharmacol. 33 509-514 (1988).
6. R. VILLALOBOS-MOLINA, A. MIYAMOTO, M.A. KOWATCH and G.S. ROTH, Europ.J.Pharmacol. 226 129-131 (1992).
7. R. BUSCHER, W. ERDBRUGGER, T. PHILIPP, O.E. BRODDE and M.C. MICHEL, Nauny-Schmiedebergs. Arch.Pharmacol. 350 592-598 (1994).
8. W. CHENG, J. COUPET, P. LI, K. REISS, C.V. HAMBY, J.M. CAPASSO, L.G. MEGGS and P. ANVERSA, Cardiovasc.Res. 28 1070-1082 (1994).
9. J. MIRONNEAU and N. MACREZ-LEPRETRE, Cell Signal. 7 471-479 (1995).
10. N. LEPRETRE, J. MIRONNEAU, S. AMAUDEAU, Z. TANFIN, S. HARBON, G. GUILLON and J. BARRONDO, J.Pharmacol.Exp.Ther. 268 167-174 (1994).
11. N. MACREZ-LEPRETRE, J.L. MORE and J. MIRONNEAU, Biochem.Biophys. Res. Commun. 218 30-34 (1996).
12. D.J. GOULD and C.E. HILL, J.Auton.Nerv.Syst. 50 139-150 (1994).
13. T.A. ESBENSHADE, T.T. THEROUX and K.P. MINNEMAN, Mol.Pharmacol. 15 591-598 (1994).
14. N.L. SIMMONS, Exp.Physiol. 75 309-319 (1990).
15. S. CHUMPYADIT, M.P. KUNG, J. VESSOTSKIE, C. FOULON, M. MU and .F. KUNG, J.Med.Chem. 37 4245-4250 (1994).
16. C.F. LAWSON, R.A. MORTIMORE, S.K. SCHLACHTER and M.W. SMITH, Meth.Find.Exp.Clin.Pharmac. 16 303-307 (1994).
17. S. TIA, J.F. WANG, N. KOTCHABHAKDI and S. VINICI, J.Neurosci. 16 3630-3640 (1996).
18. Z. WANG, J. ARDEN and W. SADEE, FEBS-Lett. 387 53-57 (1996).
19. R.H. MOORE, N. SADOVNIKOFF, S. HOFFENBERG, S. LIU, P. WOODFORD, K. ANGELIDES, J.A.TRIAL, N.D. CARSRUD, B.F. DICKEY and B.J. KNOLL, J Cell Sci. 108 2983-2991 (1995).
20. L.P. DAGGETT, A.I. SACAAN, M. AKONG, S.P. RAO, S.D. HESS, C. LIAW, A. URRUTIA, C. JACHEE, S.B. ELLIS and J. DREESSEN, Neuropharmacology 34 871-886 (1995).
21. Y.Y. GUAN, C.Y. KWAN and E.E. DANIEL, Can.J.Physiol.Pharmacol. 66 1053-1056 (1988).
22. B. BRUNE and V. ULLRICH, J.Biol.Chem. 266 19232-19237 (1991).
23. J.K. FOSKETT and D. WONG, J.Biol.Chem. 266 14535-14538 (1991).
24. I.M. ROBINSON, T.R. CHEEK and R.D. BURGOYNE, Biochem.J. 288 457-463 (1992).
25. J. GROMADA, P. RORSMAN, S. DISSING and B.S. WULFF, FEBS Letters 373 182-186 (1995).
26. L. ANDERSON, C.L. ALEXANDER, E. FACCENDA and K.A. EIDNE, Biochem.J. 311 385-392 (1995).
27. B. LJUNG and A. KJELLSTED, J.Cardiovasic.Pharmacol. 10 S82-88 (1987).
28. K.P. MINNEMAN, TL. THEROUX, S. HOLLINGER, C. HAN and T.A. ESBENSHADE, Mol.Pharmacol. 46 929- 936 (1994).
29. K. HORIE, H. ITOH and G. TSUJIMOTO, Mol.Pharmacol. 48 392-400 (1995).